Medicinal Chemistry Perspectives on PFAS in Drug Design: Fluorinated Motifs, Innovation, and Patient Impact
Abstract
Concerns about long-chain per- and polyfluoroalkyl substances (PFAS), e.g. PFOS, PFOA, PFNA, have led to broad regulatory initiatives that often treat PFAS as a single class, unintentionally encompassing carbon-fluorine motifs essential to medicinal chemistry. This Perspective examines the implications for small-molecule drug discovery, focusing on -CF2- and -CF3 groups used in active pharmaceutical ingredients. Survey data from medicinal chemistry departments across multiple pharmaceutical organizations highlight the routine use of fluorinated substituents to optimize target engagement, selectivity, permeability, metabolic stability, and systemic exposure, particularly in demanding therapeutic areas. Examples from recently approved drugs and the WHO Model List of Essential Medicines demonstrate how these motifs enable translation of challenging targets into effective therapies. We further discuss the risks of generalized PFAS classifications for pharmaceuticals and emphasize the need for context-specific regulatory approaches that preserve innovation while addressing environmental concerns.
Read the paper
Related studies
- Noninvasive and Point-of-Care Surface-Enhanced Raman Scattering (SERS)-Based Breathalyzer for Mass Screening of Coronavirus Disease 2019 (COVID-19) under 5 min
- De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus)
- Molecular Characterization and Expression Profiling of Tomato GRF Transcription Factor Family Genes in Response to Abiotic Stresses and Phytohormones
- Assembly of Tight Junction Strands: Claudin-10b and Claudin-3 Form Homo Tetrameric Building Blocks that Polymerise in a Channel-Independent Manner
- Update of the Pompe variant database for the prediction of clinical phenotypes: Novel disease‐associated variants, common sequence variants, and results from newborn screening
- Machine Learning-Based SERS Chemical Space for Two-Way Prediction of Structures and Spectra of Untrained Molecules
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.